Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Cintas, Adjusts Price Target To $210 (4:1 forward stock split)

Author: Benzinga Newsdesk | September 13, 2024 12:16pm
Barclays analyst Manav Patnaik maintains Cintas (NASDAQ:CTAS) with a Overweight, adjusts target to $210 from $850 (4:1 forward stock split).

Posted In: CTAS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist